MSI Principal Investigator John Ohlfest (Masonic Cancer Center, Departments of Pediatrics and Neurosurgery) passed away on January 21, 2013. Professor Ohlfest’s research concerned the treatment of brain tumors using gene therapy and novel immunotherapies intended to boost a patient’s immune system to attack cancer. He used MSI for bioinformatics tools and sequencing software to support this research.
An obituary of Professor Ohlfest appears on the Masonic Cancer Center website. The staff at MSI extends their deepest condolences to his family, friends, and colleagues.